Search Articles — Sudonull

Search Results

From other projects

A New Look at Alzheimer's Disease: Roche Tests Spinal ASO Therapy

https://ymaho.com/a-new-look-at-alzheimer-s-disease-roche-tests-spinal-aso-therapy

Roche has initiated Phase I trials of intrathecal ASO against ApoE for early Alzheimer's disease. Why this is a revolution, who will benefit, and hidden risks. Read the analysis.

AI diagnosis of Alzheimer's disease using MRI: 94% accuracy

https://ymaho.com/ai-diagnosis-of-alzheimer-s-disease-using-mri-94-accuracy

UCSF neural network predicts transition from MCI to Alzheimer's disease within 5 years with 94% accuracy using a single MRI. Alternative to PET and lumbar puncture. Details in the article.

Lecanemab in Alzheimer's disease: 27% slowing

https://ymaho.com/lecanemab-in-alzheimer-s-disease-27-slowing

Lecanemab is the first drug with full FDA approval that slows cognitive decline by 27%. Learn about efficacy, risks, and therapy availability.

Subcutaneous Lecanemab: FDA Priority Status 2026

https://ymaho.com/subcutaneous-lecanemab-fda-priority-status-2026

FDA extended review of subcutaneous Lecanemab for therapy initiation. Learn about the new standard of home Alzheimer's treatment and approval forecasts.

Trending Now